BRPI0412850A - misturas de oligossacarìdeos derivados de heparina, o respectivo preparo e as composições farmacêuticas que as contêm - Google Patents

misturas de oligossacarìdeos derivados de heparina, o respectivo preparo e as composições farmacêuticas que as contêm

Info

Publication number
BRPI0412850A
BRPI0412850A BRPI0412850-8A BRPI0412850A BRPI0412850A BR PI0412850 A BRPI0412850 A BR PI0412850A BR PI0412850 A BRPI0412850 A BR PI0412850A BR PI0412850 A BRPI0412850 A BR PI0412850A
Authority
BR
Brazil
Prior art keywords
heparin
mixtures
pharmaceutical compositions
compositions containing
preparation
Prior art date
Application number
BRPI0412850-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Volker Laux
Pierre Mourier
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0412850A publication Critical patent/BRPI0412850A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0412850-8A 2003-07-24 2004-07-22 misturas de oligossacarìdeos derivados de heparina, o respectivo preparo e as composições farmacêuticas que as contêm BRPI0412850A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309041A FR2857971B1 (fr) 2003-07-24 2003-07-24 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2004/001943 WO2005010051A2 (fr) 2003-07-24 2004-07-22 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
BRPI0412850A true BRPI0412850A (pt) 2006-10-03

Family

ID=33561051

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412850-8A BRPI0412850A (pt) 2003-07-24 2004-07-22 misturas de oligossacarìdeos derivados de heparina, o respectivo preparo e as composições farmacêuticas que as contêm

Country Status (39)

Country Link
EP (1) EP1651677B1 (enExample)
JP (1) JP4865552B2 (enExample)
KR (1) KR101125517B1 (enExample)
CN (1) CN1852926B (enExample)
AR (1) AR045917A1 (enExample)
AT (1) ATE487741T1 (enExample)
AU (1) AU2004259111B2 (enExample)
BR (1) BRPI0412850A (enExample)
CA (1) CA2533555A1 (enExample)
CR (1) CR8201A (enExample)
CY (1) CY1111165T1 (enExample)
DE (1) DE602004030015D1 (enExample)
DK (1) DK1651677T3 (enExample)
EC (1) ECSP066305A (enExample)
ES (1) ES2355827T3 (enExample)
FR (1) FR2857971B1 (enExample)
GT (1) GT200400145A (enExample)
HN (1) HN2004000250A (enExample)
IL (1) IL173206A (enExample)
MA (1) MA27928A1 (enExample)
ME (1) MEP11608A (enExample)
MX (1) MXPA06000336A (enExample)
MY (1) MY136769A (enExample)
NO (1) NO20060821L (enExample)
NZ (1) NZ544717A (enExample)
OA (1) OA13197A (enExample)
PA (1) PA8606801A1 (enExample)
PE (1) PE20050246A1 (enExample)
PL (1) PL1651677T3 (enExample)
PT (1) PT1651677E (enExample)
RS (1) RS20060044A (enExample)
RU (1) RU2346005C2 (enExample)
SI (1) SI1651677T1 (enExample)
TN (1) TNSN06025A1 (enExample)
TW (1) TWI369208B (enExample)
UA (1) UA89356C2 (enExample)
UY (1) UY28435A1 (enExample)
WO (1) WO2005010051A2 (enExample)
ZA (1) ZA200600657B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589145B2 (en) 2004-04-15 2009-09-15 Exxonmobil Chemical Patents Inc. Syndiotactic rich polyolefins
EP2447285A3 (en) * 2006-05-25 2013-01-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
CN101711771B (zh) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制法和药物组合物
DK3144325T3 (da) * 2010-09-14 2021-01-25 Univ Miyazaki Heparin med høj renhed og fremstillingsfremgangsmåde dertil
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
CN102558392A (zh) * 2010-12-14 2012-07-11 王芃 一种高抗FXa、低抗FIIa低分子肝素钠的制备方法
CN102816255B (zh) * 2011-06-10 2015-11-25 王芃 一种超低分子肝素钠的制备方法
EP2980103B1 (en) 2013-03-26 2020-11-04 Jiuzhitang Co., Ltd. Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN103864959A (zh) * 2014-04-03 2014-06-18 中国药科大学 一种肝素十二糖抗动脉粥样硬化的用途
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
IT1284143B1 (it) * 1996-09-06 1998-05-08 Istituto Scient Di Chimica E B Eparansolfati semi-sintetici ad elevata attivita' antimetastica e ridotto rischio emorragico
AU7753898A (en) * 1997-06-06 1998-12-21 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
FR2807043B1 (fr) * 2000-03-28 2002-11-22 Aventis Pharma Sa Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
CA2458852A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP1651677A2 (fr) 2006-05-03
MXPA06000336A (es) 2006-03-30
TW200522970A (en) 2005-07-16
KR20060059974A (ko) 2006-06-02
JP2006528614A (ja) 2006-12-21
IL173206A (en) 2010-11-30
PE20050246A1 (es) 2005-06-02
NZ544717A (en) 2009-09-25
SI1651677T1 (sl) 2011-03-31
GT200400145A (es) 2005-03-16
AU2004259111A1 (en) 2005-02-03
AR045917A1 (es) 2005-11-16
RU2006105384A (ru) 2007-09-10
UA89356C2 (ru) 2010-01-25
CN1852926A (zh) 2006-10-25
ES2355827T3 (es) 2011-03-31
CY1111165T1 (el) 2015-06-11
DE602004030015D1 (de) 2010-12-23
CN1852926B (zh) 2010-05-12
WO2005010051A3 (fr) 2005-06-16
PT1651677E (pt) 2011-02-08
ATE487741T1 (de) 2010-11-15
AU2004259111B2 (en) 2009-06-11
KR101125517B1 (ko) 2012-03-23
ECSP066305A (es) 2006-07-28
IL173206A0 (en) 2006-06-11
ZA200600657B (en) 2007-05-30
PA8606801A1 (es) 2005-02-04
DK1651677T3 (da) 2011-02-28
RU2346005C2 (ru) 2009-02-10
CR8201A (es) 2006-09-22
MEP11608A (en) 2010-06-10
JP4865552B2 (ja) 2012-02-01
WO2005010051A2 (fr) 2005-02-03
TNSN06025A1 (en) 2007-10-03
PL1651677T3 (pl) 2011-04-29
TWI369208B (en) 2012-08-01
FR2857971B1 (fr) 2005-08-26
CA2533555A1 (fr) 2005-02-03
NO20060821L (no) 2006-04-20
HK1094806A1 (zh) 2007-04-13
RS20060044A (sr) 2008-06-05
EP1651677B1 (fr) 2010-11-10
MA27928A1 (fr) 2006-06-01
UY28435A1 (es) 2005-02-28
HN2004000250A (es) 2006-06-29
OA13197A (fr) 2006-12-13
MY136769A (en) 2008-11-28
FR2857971A1 (fr) 2005-01-28

Similar Documents

Publication Publication Date Title
BR0313060A (pt) Composições farmacêuticas aquosas de 2,6-diisopropilfenol
CY1107992T1 (el) Συνθεσεις πολυαμιδο-αμικου οξεος υδατικης βασεως
BR0106649A (pt) Composição fertilizante contendo enxofre e processo para preparação da mesma
BR0009651A (pt) Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas
BRPI0414492A (pt) solvato acetÈnico do dimetóxi docetaxel e seu processo de preparação
BRPI0418148A (pt) composto, prodroga de um composto, modulador da função do receptor gpr40, agente farmacêutico, uso de um composto e métodos de modificação de uma função do receptor gpr40 em um mamìfero, de profilaxia ou tratamento de diabetes em um mamìfero e de produção de um composto
BR9908537A (pt) Copolìmeros biocompatìveis e utilização dos mesmos
BRPI0412671A (pt) conjugados de um polìmero e uma proteìna ligados por um grupo de ligação de oxima
BR0002276A (pt) Conjugado, composição que compreendeconjugados, composição farmacêutica, utilizaçãode um conjugado ou composição e processso paraa preparação de compostos
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BR9814308A (pt) Derivados de acilguanidina como inibidores de ressorção óssea e como antagonistas de receptores de vitronectina
BR0014214A (pt) Imidazoquinolinas substituìdas com amida
BR0007487A (pt) Difenil-uréias substituìdas com w-carbóxi-arilas como inibidores de raf cinase
BR0211995A (pt) Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação
BRPI0412850A (pt) misturas de oligossacarìdeos derivados de heparina, o respectivo preparo e as composições farmacêuticas que as contêm
BR0112612A (pt) Misturas de polissacarìdeos sulfatados, processo de preparação das mesmas e composições farmacêuticas
ES2091964T3 (es) Tejido estabilizado frente a radiacion con caracteristicas de olor mejoradas.
BR9813391A (pt) Composição de epo, preparado farmacêutico e processos para produzir uma composição de epo e para aumentar a atividade especìfica de uma composição de epo
BR0208468A (pt) Camsilato de amlodipina e processo para sua preparação
BR0211852A (pt) Polìmeros aromáticos de monovinilideno baseados em borrachas de polibutadieno de peso molecular elevado altamente lineares e um processo para sua preparação
BRPI0408827A (pt) composições oftálmicas preservadas
BR0308690A (pt) Polisobutenaminas, processo para preparação e uso das mesmas, concentrado de aditivo, e, composição de combustìvel
BR0016383A (pt) Polìmeros aromáticos de monovinilideno com propriedades melhoradas e um processo para sua preparação
BR0307783A (pt) Composições e métodos para tratar doenças do tecido epitelial e retinal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2264 DE 27/05/2014.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI